微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 66.69% | -9.69% | 0.09% | 30/130 | 51.33% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 66.63% | -8.07% | -3.86% | 38/130 | 52.41% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 69.3% | -1.93% | -3.11% | 32/130 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 71.52% | -1.19% | -3.13% | 23/130 | 53.59% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 73.84% | 7.99% | 1.88% | 22/130 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 72.48% | -4.67% | 2.56% | 20/130 | 53.39% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 70.67% | -4.35% | -2.38% | 24/130 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 72.39% | -2.86% | 5.87% | 17/130 | 53.53% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 68.37% | -15.03% | -10.07% | 32/130 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 76.03% | -1.41% | 2.9% | 15/130 | 53.92% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 73.88% | -3.67% | -0.85% | 21/130 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 74.52% | -2.6% | -7.39% | 18/130 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 80.47% | 2% | 4.35% | 12/130 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 77.11% | 6.22% | 0.54% | 14/130 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 76.7% | 2% | 0.25% | 17/130 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 76.51% | 8.47% | 5.39% | 19/130 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 72.6% | 4.99% | 2.93% | 35/130 | 59.67% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 70.54% | 2% | 2% | 34/130 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 69.15% | 8.8% | 8.8% | 35/130 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 63.56% | -9.92% | -9.92% | 47/130 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 70.56% | 2% | 2% | 29/130 | 55.34% | 正海生物 | 94.38% | 行业排名> |